![\"\"](\"https:\/\/i0.wp.com\/www.mbc.manchester.ac.uk\/barrangroup\/wp-content\/uploads\/sites\/2\/2019\/07\/c8an01448e-f1_hi-res.gif?resize=750%2C1029&ssl=1\")
<\/p>\nHigh throughput screening (HTS) of molecular analytes is in high demand from and implemented in many areas of chemistry, medicine and industrial biotechnology including the discovery of biomarkers and the development of new chemical entities. Despite its prevalence, technical challenges remain in many of the new application areas of HTS which require rapid results from complex mixtures, for example in: screening biotransformations; targeted metabolomics; and in locating drugs and\/or metabolites in biological matrices. Common to all of these are lengthy and costly sample preparation stages, involving recovery from cell cultures, extractions followed by low throughput LC-MS\/MS methods or specific fluorescence measurements. In the latter the target molecules need to be inherently fluorescent or to include a fluorescent label or tag which can adversely influence a cellular system. Direct infusion mass spectrometry coupled with robotic sample infusion is a viable contender for information rich HTS with sub-second analysis times, and recent developments in ambient ionisation have heralded a new era where screening can be performed on crude cell lysates or even from live cells. Besides commercially available technologies such as RapidFire, Acoustic Mist Ionisation, and the TriVersa ChipMate there are promising new developments from academic groups. Novel applications using desorption electrospray ionisation, microfluidics, rapid LC-separation and \u2018one cell\u2019 direct infusion methods offer much potential for increasing throughput from \u2018messy\u2019 complex samples and for significantly reducing the amount of material that needs to be analysed. Here we review recent advances in HTS coupled with MS with an emphasis on methods that reduce or remove all sample preparation and will facilitate single cell screening approaches.<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
Emily E. Kempa <\/span>a<\/span><\/sup>,\u00a0Katherine A. Hollywood <\/span>b<\/span><\/sup>,\u00a0Clive A. Smith <\/span>c<\/span><\/sup>\u00a0and\u00a0<\/span>Perdita E. Barran <\/span>*ab<\/span><\/sup>\u00a0<\/em>
\na<\/span><\/sup>Michael Barber Centre for Collaborative Mass Spectrometry, Manchester Institute of Biotechnology, The University of Manchester, Manchester, M1 7DN, UK. E-mail:\u00a0Perdita.Barran@Manchester.ac.uk<\/a><\/span>\u00a0<\/em>
\nb<\/span><\/sup>Manchester Centre for Synthetic Biology of Fine and Speciality Chemicals (SYNBIOCHEM), Manchester Institute of Biotechnology, The University of Manchester, Manchester M1 7DN, UK<\/span>\u00a0<\/em>
\nc<\/span><\/sup>Sphere Fluidics Limited, The Jonas-Webb Building, Babraham Research Campus, Babraham, Cambridge, CB22 3AT, UK<\/span><\/em><\/p>\n